D. Perry

发表

Mapping sequence specific DNA-protein interactions: a versatile, quantitative method and its application to transcription factor XF1.

B. Luo, D. Perry, L. Zhang, 1997, Journal of molecular biology.

Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort

R. Keenan, D. Perry, M. Laffan, 2009, Journal of thrombosis and haemostasis : JTH.

Guidelines on oral anticoagulation with warfarin – fourth edition

D. Perry, T. Baglin, M. Makris, 2011, British journal of haematology.

A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.

Sri V. V. Deevi, W. Ouwehand, A. Attwood, 2016, Blood.

Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp)

R. Carrell, D. Perry, M. Wardell, 1994, The Journal of clinical investigation.

Antithrombin Cambridge II, 384 Ala to Ser Further evidence of the role of the reactive centre loop in the inhibitory function of the serpins

R. Carrell, D. Perry, R. Tait, 1991, FEBS Letters.

Antithrombin Cambridge, 384 Ala to Pro: A new variant identified using the polymerase chain reaction

R. Carrell, D. Perry, M. Daly, 1989, FEBS letters.

Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes

William J. Astle, Dorothy A. Thompson, Sri V. V. Deevi, 2018, American journal of human genetics.

The UK National External Quality Assessment Scheme for Heritable Bleeding Disorders

D. Perry, S. Kitchen, A. Goodeve, 2014, Seminars in Thrombosis & Hemostasis.

A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO

S. Watson, D. Perry, A. Mumford, 2006, British journal of haematology.

Genetics of haemostasis

D. Perry, G. Jayandharan, E. Tuddenham, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Dynamic analysis of platelet deposition to resolve platelet adhesion receptor activity in whole blood at arterial shear rate

D. Perry, D. Bihan, R. Farndale, 2014, Platelets.

Don't be a clot: a radiologist's guide to haemostasis including novel antiplatelet and anticoagulant therapies.

E. Godfrey, A. Shaw, D. Perry, 2011, Clinical radiology.

A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.

William J. Astle, Sylvia Richardson, Kathleen Stirrups, 2016, Blood.

Role of the Thrombelastograph as an adjunctive test in thrombophilia screening

D. Perry, G. Hamilton, A. Handa, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

PLATELETS AND THROMBOPOIESIS A gain-of-function variant in DIAPH 1 causes dominant macrothrombocytopenia and hearing loss

William J. Astle, Sjoert B. G. Jansen, S. Richardson, 2016 .

A gain-of-function DIAPH1 variant causes dominant macrothrombocytopenia and hearing loss

William J. Astle, Sandrine, S. Richardson, 2015 .

Prevalence of antithrombin deficiency in the healthy population

R. Carrell, D. Perry, I. Walker, 1994, British journal of haematology.

Plasma and plasma products in the treatment of massive haemorrhage.

W. Erber, D. Perry, 2006, Best practice & research. Clinical haematology.

Genetic testing in bleeding disorders

J. Oldenburg, O. el-Maarri, D. Perry, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

The UK National External Quality Assessment Scheme (UK NEQAS) for molecular genetic testing in haemophilia

D. Perry, S. Kitchen, A. Goodeve, 2006, Thrombosis and Haemostasis.

Hydrolink gels: a rapid and simple approach to the detection of DNA mutations in thromboembolic disease.

R. Carrell, D. Perry, R. Carrell, 1992, Journal of clinical pathology.

Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease.

D. Lomas, D. Perry, D. Bilton, 1998, The European respiratory journal.

Next ‐ generation sequencing for the diagnosis of MYH9 ‐ RD

Sri V. V. Deevi, K. Stirrups, W. Ouwehand, 2019 .

Multiple DNA-binding factors interact with overlapping specificities at the aryl hydrocarbon response element of the cytochrome P450IA1 gene

D. Perry, J. Fagan, F. Saatcioglu, 1990, Molecular and cellular biology.

Antithrombin Cambridge II (Ala384Ser): Clinical, Functional and Haplotype Analysis of 18 Families

R. Carrell, D. Perry, R. Tait, 1998, Thrombosis and Haemostasis.

Antithrombin Mutation Database: 2nd (1997) Update

D. Cooper, D. Perry, S. Thein, 1997, Thrombosis and Haemostasis.

Two antithrombin mutations in a compound heterozygote: Met20Thr and Tyr166Cys

R. Carrell, D. Perry, B. Colvin, 1995, American journal of hematology/oncology.

Antithrombin and its inherited deficiencies.

D. Perry, 1994, Blood reviews.

Antithrombin Rouen‐IV 24 Arg→Cys The amino‐terminal contribution to heparin binding

R. Carrell, D. Perry, S. Brennan, 1990, FEBS letters.

Aryl hydrocarbon (Ah) receptor DNA-binding activity. Sequence specificity and Zn2+ requirement.

D. Perry, J. Fagan, F. Saatcioglu, 1990, The Journal of biological chemistry.

Factor VII deficiency.

D. Perry, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Factor VII Deficiency.

D. Perry, 2002, British journal of haematology.

Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiency.

D. Perry, K. Pasi, C. Lee, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation

D. Perry, G. Dolan, A. Mumford, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders

Sylvia Richardson, Augusto Rendon, Sjoert B. G. Jansen, 2015, Genome Medicine.

A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies

Sylvia Richardson, Kathleen Stirrups, Wendy N. Erber, 2016, Science Translational Medicine.

Factor X deficiency.

D. Perry, J. Uprichard, 2002, Blood reviews.

A framework for genetic service provision for haemophilia and other inherited bleeding disorders

D. Perry, A. Fryer, G. Dolan, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Thromboembolism Associated with Fertility Treatment

D. Perry, E. Symington, 2015 .

Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency

D. Perry, N. O'Connell, C. Lee, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

THE UNHINGED ANTITHROMBINS

R. Carrell, D. Perry, 1996 .

Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal.

D. Perry, C. Lee, I. Nițu, 1998, Clinical and laboratory haematology.

α1-Antitrypsin deficiency alleles and the Taq-I G→A allele in cystic fibrosis lung disease

D. Lomas, D. Perry, D. Bilton, 2002 .

Sustained increase in haemoglobin and RBC following long‐term administration of recombinant human erythropoietin to patients with homozygous beta‐thalassaemia

D. Perry, G. Dover, E. Rachmilewitz, 1995, British journal of haematology.

AAV5–Factor VIII Gene Transfer in Severe Hemophilia A

D. Perry, M. Laffan, S. Rangarajan, 2017, The New England journal of medicine.

Antithrombin III Mutation Database: First Update

D. Cooper, D. Perry, S. Thein, 1993, Thrombosis and Haemostasis.

Asymptomatic coinheritance of heterozygous plasminogen deficiency and the factor VLeiden mutation

D. Perry, R. Tait, I. Walker, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A review of long‐term prophylaxis in the rare inherited coagulation factor deficiencies

D. Perry, T. Todd, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Molecular genetics of human antithrombin deficiency

R. Carrell, D. Perry, 1996, Human mutation.

Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools

D. Perry, S. Perkins, Christine A. Lee, 2005, Human mutation.

Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura

D. Perry, T. Baglin, K. Bowles, 2006, British journal of haematology.

Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: effects of differing forms of hormonal contraception

D. Perry, K. Pasi, W. Yoong, 2003, European journal of haematology.

Treating venous thromboembolism: enoxaparin.

D. Perry, 2001, Hospital medicine.

Factor X and Factor X Deficiency

D. Perry, 2007 .

Thromboembolism and the combined oral contraceptive pill

D. Perry, K. Pasi, C. A. Lee, 1995, The Lancet.

Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion

S. Sawcer, D. Perry, P. Hodgkins, 1995, Eye.

Isolation of DNA and RNA.

D. Perry, 1999, Methods in molecular medicine.

Analysis and results of the recombinant factor VIIa extended-use registry.

D. Perry, M. Laffan, D. O'shaughnessy, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Mechanism of action of interferon-tau in the uterus during early pregnancy.

D. Perry, T. R. Hansen, J. Pru, 2019, Journal of reproduction and fertility. Supplement.

Resistance to activated protein C and factor V Leiden.

D. Perry, K. Pasi, 1997, QJM : monthly journal of the Association of Physicians.

Post-gamma globulin. II. Radioimmunoassay determination of levels of post-gamma globulin and beta 2-microglobulin.

D. Perry, E. Vokac, M. D. Poulik, 1983, Clinica chimica acta; international journal of clinical chemistry.

Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor VLeiden mutation

D. Perry, R. Tait, I. Walker, 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Veno-occlusive disease: cytokines, genetics, and haemostasis.

D. Perry, J. Coppell, S. Brown, 2003, Blood reviews.

Radioimmunoassay (RIA) of Post-Gamma Globulin Using a Monoclonal Antibody

D. Perry, M. D. Poulik, T. Sekine, 1982 .

Cloning of interferon-stimulated gene 17: the promoter and nuclear proteins that regulate transcription.

D. Perry, T. R. Hansen, K. Austin, 1999, Molecular endocrinology.

Novel cationic lipidic peptide dendrimer vectors in vitro gene delivery

D. Perry, H. Bayele, T. Sakthivel, 1999 .

Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A

D. Perry, S. Fong, S. Rangarajan, 2019, Research and practice in thrombosis and haemostasis.

Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency

D. Perry, T. Baglin, H. Watson, 2007, British journal of haematology.

Factor X and its deficiency states

D. Perry, 1997, Haemophilia : the official journal of the World Federation of Hemophilia.

Antithrombin III: A Database of Mutations

D. Perry, S. Thein, D. Lane, 1991, Thrombosis and Haemostasis.

Bovine granulocyte chemotactic protein-2 is secreted by the endometrium in response to interferon-tau (IFN-τ)

D. Perry, T. R. Hansen, G. Johnson, 1997, Endocrine.

FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations

D. Perry, G. Dolan, M. Laffan, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Thrombelastography

D. Perry, N. Salooja, 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Point‐of‐care testing in haemostasis

D. Fitzmaurice, D. Perry, S. Mallett, 2010, British journal of haematology.

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany

L. Mantovani, J. Blatny, D. Perry, 2017, European journal of haematology.

Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B.

J. Oldenburg, D. Perry, M. Ozelo, 2016, Thrombosis and haemostasis.

Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein ( rFIXFc ) in subjects with haemophilia

J. Oldenburg, D. Perry, M. Ozelo, 2017 .

Clinical haemophilia Long-term safety and efficacy of recombinant factor VIII Fc fusion protein ( rFVIIIFc ) in subjects with haemophilia

D. Perry, B. Konkle, K. Pasi, 2016 .

Long-Term Safety and Efficacy of Recombinant Factor VIII FC (RFVIIIFC) in Adults and Adolescents With Severe Haemophilia A: An Interim Analysis of The ASPIRE Study

D. Perry, B. Konkle, J. Mahlangu, 2015 .

Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.

J. Dumont, D. Perry, L. Valentino, 2013, The New England journal of medicine.

Long‐acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B‐LONG study

C. Hermans, D. Perry, M. Ozelo, 2015, British journal of haematology.

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

J. Dumont, I. Nestorov, D. Perry, 2014, Blood.

Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A‐LONG study subjects with severe haemophilia A

D. Perry, D. Quon, J. Mahlangu, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Carrier detection in the haemophilias

David James Perry, D. Perry, 1992 .

Into the future with novel emerging therapies for haemophilia

D. Perry, 2015 .

Detection of known haemophilia B mutations and carrier testing by microarray.

Christine A. Lee, D. Perry, A. Chuansumrit, 2005, Thrombosis and haemostasis.

Guidelines on the investigation and management of venous thrombosis at unusual sites

D. Perry, T. Baglin, M. Makris, 2012, British journal of haematology.

The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays

A. Burroughs, D. Perry, A. Zambruni, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Long‐term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A

D. Perry, B. Konkle, K. Pasi, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

hemophilia A Phase 3 study of recombinant factor VIII Fc fusion protein in severe

J. Dumont, I. Nestorov, D. Perry, 2014 .

The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

P. Giangrande, D. Perry, A. Miners, 2016, European journal of haematology.

A computer‐based model to assess costs associated with the use of factor VIII and factor IX one‐stage and chromogenic activity assays

D. Perry, K. Friedman, R. Ko, 2016, Journal of thrombosis and haemostasis : JTH.

Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.

William J. Astle, Suthesh Sivapalaratnam, Kathleen Stirrups, 2017, Blood.

Somatic gene therapy for haemophilia: Some counselling issues for today and tomorrow

R. Miller, D. Perry, P. Fields, 2002 .

Laboratory assay measurement of modified clotting factor concentrates: a review of the literature and recommendations for practice

D. Perry, G. Young, 2019, Journal of thrombosis and haemostasis : JTH.

Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency

D. Perry, S. Perkins, E. Tuddenham, 2009, Thrombosis and Haemostasis.

Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domain

D. Perry, T. Baglin, M. Gattens, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Gene therapy trials in the UK: is haemophilia a suitable 'model'?

D. Perry, G. Dolan, K. Pasi, 2004, Clinical medicine.

Long-Term Safety and Efficacy of rFVIIIFc in Adults and Adolescents with Severe Hemophilia A: A Longitudinal Analysis of A-LONG and ASPIRE

D. Perry, B. Konkle, K. Pasi, 2015 .

Title Detection of known haemophilia B mutations and carrier testingby microarray

Christine A. Lee, D. Perry, A. Chuansumrit, 2005 .

Ectopic transcript analysis in human antithrombin deficiency.

D. Perry, 1999, Methods in molecular medicine.

Next‐generation sequencing for the diagnosis of MYH9‐RD: Predicting pathogenic variants

Sri V. V. Deevi, Nicholas S. Gleadall, K. Stirrups, 2019, Human mutation.

Next‐generation sequencing for the diagnosis ofMYH9‐RD

Sri V. V. Deevi, K. Stirrups, W. Ouwehand, 2019 .

Thromboelastography: An effective screening test for prothrombotic states

D. Perry, K. Pasi, G. Hamilton, 1998 .

Internal jugular vein thrombosis following in-vitro fertilization in a woman with protein S deficiency and heterozygosity for the prothrombin 3' UTR mutation, despite anticoagulation with heparin.

D. Perry, R. Thomas, W. Reid, 2001, Blood Coagulation and Fibrinolysis.

Clinical guidelines for testing for heritable thrombophilia

Elaine Gray, Ian Mackie, Beverley J Hunt, 2010, British journal of haematology.

Deep vein thrombosis followed by internal jugular vein thrombosis as a complication of in vitro fertilization in a woman heterozygous for the prothrombin 3′ UTR and factor V Leiden mutations

D. Perry, L. A. Kay, Brett McGowan, 2003, American journal of hematology.

The Use of Recombinant Factor VIIa in Surgical Bleeding in Nonhemophiliac Patients

D. Perry, N. O'Connell, 2003 .

The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease

R. Carrell, D. Perry, R. Luddington, 1991, British journal of haematology.

Confirmation of genetic testing results in haemostasis and thrombosis – survey of current practice in the field

D. Perry, S. Kitchen, A. Goodeve, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Trinucleotide repeat polymorphism in the human antithrombin III (AT3) gene.

D. Perry, 1993, Human molecular genetics.

A comprehensive high-throughput sequencing test for the diagnosis of inherited bleeding , thrombotic and platelet disorders

Sri V. V. Deevi, W. Ouwehand, J. Jolley, 2015 .

Recombinant FVIIa in the management of uncontrolled hemorrhage

D. Perry, N. O'Connell, O. Smith, 2003, Transfusion.

Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.

D. Perry, R. I. Harris, R. Welch, 1987, The Journal of hospital infection.

Hemostasis and thrombosis protocols

David J. Perry, D. Perry, K. Pasi, 1999 .

Ectopic transcript analysis in human antithrombin deficiency.

D. Perry, 1995, Blood Coagulation and Fibrinolysis.

Pharmacokinetics, Safety, and Efficacy Of Long-Lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Adolescent Subjects With Hemophilia B: A Subgroup Analysis Of The B-LONG Study

D. Perry, L. Valentino, M. Ozelo, 2013 .

Inherited protein C deficiency, protein S deficiency and hyperhomocysteinaemia in a patient with hereditary spherocytosis.

D. Perry, J. Luckit, C. P. Taylor, 1999, Clinical and laboratory haematology.

Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia

D. Perry, J. O'Donnell, 2002, Expert opinion on pharmacotherapy.

Gene mutations and three‐dimensional structural analysis in 13 families with severe factor X deficiency

P. Mannucci, D. Perry, E. Santagostino, 2002, British journal of haematology.

Screening for Mutations in DNA by Single-Stranded Conformation Polymorphism (SSCP) Analysis.

D. Perry, 1999, Methods in molecular medicine.

2B or not 2B? Differential identification of Type 2B, versus pseudo‐,von Willebrand disease

D. Perry, I. Whalley, 2007, British journal of haematology.

Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion

D. Perry, K. Bunce, P. Hykin, 2001, The British journal of ophthalmology.

THROMBOSIS AND HEMOSTASIS A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders